FR2415301A1 - Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon - Google Patents

Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon

Info

Publication number
FR2415301A1
FR2415301A1 FR7900498A FR7900498A FR2415301A1 FR 2415301 A1 FR2415301 A1 FR 2415301A1 FR 7900498 A FR7900498 A FR 7900498A FR 7900498 A FR7900498 A FR 7900498A FR 2415301 A1 FR2415301 A1 FR 2415301A1
Authority
FR
France
Prior art keywords
determination
composition
dual receiver
specific fixation
ligand sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7900498A
Other languages
English (en)
Other versions
FR2415301B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Publication of FR2415301A1 publication Critical patent/FR2415301A1/fr
Application granted granted Critical
Publication of FR2415301B1 publication Critical patent/FR2415301B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne l'industrie de l'analyse biochimique. Pour améliorer l'efficacité des déterminations par fixation spécifique avec un récepteur double, on utilise un récepteur complexe de structure :
FR7900498A 1978-01-23 1979-01-10 Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon Granted FR2415301A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87147878A 1978-01-23 1978-01-23
US05/930,130 US4271140A (en) 1978-01-23 1978-08-01 Method and composition for double receptor, specific binding assays

Publications (2)

Publication Number Publication Date
FR2415301A1 true FR2415301A1 (fr) 1979-08-17
FR2415301B1 FR2415301B1 (fr) 1984-05-11

Family

ID=27128209

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7900498A Granted FR2415301A1 (fr) 1978-01-23 1979-01-10 Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon

Country Status (5)

Country Link
US (1) US4271140A (fr)
JP (1) JPS54104391A (fr)
DE (1) DE2902400A1 (fr)
FR (1) FR2415301A1 (fr)
GB (1) GB2012954B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019277A1 (fr) * 1979-05-21 1980-11-26 New York Blood Center, Inc. Procédé de détection d'un antigène dans un échantillon
EP0064318A1 (fr) * 1981-05-02 1982-11-10 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis Procédé et trousse pour l'essai d'anticorps contre des antigènes solubles
FR2542871A1 (fr) * 1983-03-15 1984-09-21 Pasteur Institut Procede de dosage en phase heterogene de substances biologiques antigeniques, mettant en oeuvre des conjugues hybrides d'anticorps et reactifs pour sa mise en oeuvre
WO1989005140A1 (fr) * 1987-12-10 1989-06-15 Arthur Randell Bradwell Agents et procede de ciblage de tumeurs
WO1993014405A1 (fr) * 1992-01-06 1993-07-22 Baxter Diagnostics Inc. Methode de dosage par capture au moyen d'une proteine de liaison

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451571A (en) * 1981-04-06 1984-05-29 University Patents, Inc. Preparation of samples for vitamin B12 and/or folate assay and assay
US4481298A (en) * 1981-04-13 1984-11-06 Amf Incorporated Pre-precipitated double antibody immunoassay method
US4994373A (en) 1983-01-27 1991-02-19 Enzo Biochem, Inc. Method and structures employing chemically-labelled polynucleotide probes
US4737453A (en) * 1984-12-12 1988-04-12 Immunomedics, Inc. Sandwich immunoassay utilizing a separation specific binding substance
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
DE69130536T2 (de) * 1990-08-02 1999-04-22 Antex Biolog Inc Adhäsionsrezeptoren für pathogene oder opportunistische mikroorganismen
IE920778A1 (en) * 1991-03-12 1992-09-23 Du Pont Method for specific binding assays using a releasable ligand
US5965379A (en) * 1991-07-19 1999-10-12 Cytimmune Sciences Inc. Method for measuring endogenous cytokines
DE69230000T2 (de) * 1991-07-19 2000-05-11 Cytimmune Sciences Inc Verfahren und testsatz zur messung von endogenen zytokinen
JP2665850B2 (ja) * 1991-11-14 1997-10-22 塩野義製薬株式会社 ｈＢＮＰのＣ端を認識するモノクロ−ナル抗体
US5518887A (en) * 1992-03-30 1996-05-21 Abbott Laboratories Immunoassays empolying generic anti-hapten antibodies and materials for use therein
US6610493B1 (en) 1993-06-17 2003-08-26 Brigham And Women's Hospital Screening compounds for the ability to alter the production of amyloid-β peptide
US6201109B1 (en) 1993-01-13 2001-03-13 Dade Behring Marburg Gmbh Assay for bone alkaline phosphatase
US5434087A (en) * 1993-02-24 1995-07-18 Abbott Laboratories Folate immunoassay utilizing folate binding protein in a multiclonal antibody format
US5536820A (en) * 1993-02-26 1996-07-16 E. I. Du Pont De Nemours And Company Avidin-binding azo reagents
WO1995011311A1 (fr) * 1993-10-20 1995-04-27 Duke University PROCEDE DE LIAISON D'UN ELEMENT AU PEPTIDE β-AMYLOÏDE
DE4420742A1 (de) * 1993-10-20 1995-04-27 Boehringer Mannheim Gmbh Synthetischer Standard für Immunoassays
WO1995021942A1 (fr) * 1994-02-15 1995-08-17 T Cell Diagnostics, Inc. Trousse de dosage immunologique comprenant des reactifs universels
JPH08178926A (ja) * 1994-10-25 1996-07-12 Sumitomo Pharmaceut Co Ltd イムノアッセイプレートおよびその用途
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
US5712103A (en) * 1995-02-13 1998-01-27 Regents Of The University Of California Diagnostic assay for the prediction of preeclampsia
US20040157262A1 (en) * 1996-04-30 2004-08-12 Michel Kohl Conjugates of haptens to beta-lactam derivatives and their use for detecting and/or quantifying haptens in solution and device for implementation thereof
SE9604575D0 (sv) 1996-12-12 1996-12-12 Biacore Ab Method and system for analyte determination
US6924153B1 (en) * 1997-03-06 2005-08-02 Quidel Corporation Quantitative lateral flow assays and devices
US6824986B1 (en) * 1997-10-06 2004-11-30 University Of Cincinnati Methods for measuring in vivo cytokine production
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex
NZ507033A (en) * 1998-03-20 2004-06-25 Univ Missouri Compositions and methods for early pregnancy diagnosis
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
US6289286B1 (en) * 1998-05-29 2001-09-11 Biacore Ab Surface regeneration of biosensors and characterization of biomolecules associated therewith
CA2270797A1 (fr) * 1998-07-27 2000-01-27 Bayer Corporation Membrane d'ecoulement transparente pour dispositifs reactifs analytiques secs
JP4219491B2 (ja) * 1999-06-18 2009-02-04 富士フイルム株式会社 乾式分析方法及び乾式分析要素
TWI237695B (en) * 1999-12-14 2005-08-11 Joy Biomedical Corp Helicobacter pylori antigens in blood
US20020102717A1 (en) * 2000-12-09 2002-08-01 Hadeed Erika Lynn Refillable, reusable pregnancy test
CA2446246A1 (fr) * 2001-05-03 2002-11-14 Immunetics, Inc. Systemes et procedes de detection d'analytes dans des liquides biologiques
WO2003043524A2 (fr) * 2001-11-20 2003-05-30 The Curators Of The University Of Missouri Compositions et methodes pour le diagnostic precoce precis de la grossesse
US20030175828A1 (en) * 2002-03-15 2003-09-18 Lazar James G. Signal amplification by Hybrid Capture
US20050214882A1 (en) * 2004-03-25 2005-09-29 Ez Bio Inc. Reagents, methods and kits for the universal rapid immuno-detection
US20090035216A1 (en) * 2007-08-03 2009-02-05 Biomonitor Aps Method for determining in vivo biopharmaceutical concentration or bioavailability
HUE034401T2 (en) * 2007-12-13 2018-02-28 Monsanto Technology Llc Preparations and methods for early pregnancy diagnosis
US8192946B2 (en) * 2008-04-10 2012-06-05 The Curators Of The University Of Missouri Assays for detecting pregnancy-associated glycoproteins
DE102010064391A1 (de) * 2010-10-29 2012-05-03 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Verfahren zur Bestimmung eines Analytgehalts einer Flüssigkeitsprobe mittels eines Bioanalysators
CN102998469A (zh) * 2012-11-20 2013-03-27 博奥赛斯（天津）生物科技有限公司 叶酸磁微粒化学发光免疫定量检测试剂盒及其制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US4000252A (en) * 1974-01-04 1976-12-28 Kenneth Kosak Immunoscintillation cell
FR2322373A1 (fr) * 1975-08-28 1977-03-25 New England Nuclear Corp Methode et necessaire de dosage immunologique d'un antigene en phase solide
US4020151A (en) * 1976-02-17 1977-04-26 International Diagnostic Technology, Inc. Method for quantitation of antigens or antibodies on a solid surface
US4053284A (en) * 1976-03-10 1977-10-11 Akzona Incorporated Continuous flow apparatus for biological testing
FR2357900A1 (fr) * 1976-07-06 1978-02-03 Becton Dickinson Co Support revetu avec un recepteur et un ligand marque pour la determination des ligands
DE2744835A1 (de) * 1976-10-07 1978-04-13 Mochida Pharm Co Ltd Immunchemisches messverfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896217A (en) * 1973-03-19 1975-07-22 Summa Corp Method and apparatus for radioimmunoassay with regeneration of immunoadsorbent
US4011308A (en) * 1974-01-04 1977-03-08 General Electric Company Method for surface immunological detection of biological particles by the use of tagged antibodies
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4108976A (en) * 1977-03-04 1978-08-22 Becton, Dickinson And Company Automated direct serum radioimmunoassay
JPS53148521A (en) * 1977-05-27 1978-12-25 Sanyo Chem Ind Ltd Hapten-antibody complex and its preparation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
US3935074A (en) * 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US4000252A (en) * 1974-01-04 1976-12-28 Kenneth Kosak Immunoscintillation cell
FR2322373A1 (fr) * 1975-08-28 1977-03-25 New England Nuclear Corp Methode et necessaire de dosage immunologique d'un antigene en phase solide
US4020151A (en) * 1976-02-17 1977-04-26 International Diagnostic Technology, Inc. Method for quantitation of antigens or antibodies on a solid surface
US4053284A (en) * 1976-03-10 1977-10-11 Akzona Incorporated Continuous flow apparatus for biological testing
FR2357900A1 (fr) * 1976-07-06 1978-02-03 Becton Dickinson Co Support revetu avec un recepteur et un ligand marque pour la determination des ligands
DE2744835A1 (de) * 1976-10-07 1978-04-13 Mochida Pharm Co Ltd Immunchemisches messverfahren

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019277A1 (fr) * 1979-05-21 1980-11-26 New York Blood Center, Inc. Procédé de détection d'un antigène dans un échantillon
EP0064318A1 (fr) * 1981-05-02 1982-11-10 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis Procédé et trousse pour l'essai d'anticorps contre des antigènes solubles
US4468470A (en) * 1981-05-02 1984-08-28 Stichting Centraal Laboratorium Van De Bloedtransfusiedienst Van Het Nederlandse Rode Kruis Method and a kit for the assay of antibodies to soluble antigens
FR2542871A1 (fr) * 1983-03-15 1984-09-21 Pasteur Institut Procede de dosage en phase heterogene de substances biologiques antigeniques, mettant en oeuvre des conjugues hybrides d'anticorps et reactifs pour sa mise en oeuvre
EP0122833A1 (fr) * 1983-03-15 1984-10-24 Institut Pasteur Procédé de dosage en phase hétérogène de substances biologiques antigéniques, mettant en oeuvre des conjugués hybrides d'anticorps et réactifs pour sa mise en oeuvre
WO1989005140A1 (fr) * 1987-12-10 1989-06-15 Arthur Randell Bradwell Agents et procede de ciblage de tumeurs
WO1993014405A1 (fr) * 1992-01-06 1993-07-22 Baxter Diagnostics Inc. Methode de dosage par capture au moyen d'une proteine de liaison

Also Published As

Publication number Publication date
US4271140A (en) 1981-06-02
GB2012954B (en) 1983-01-12
GB2012954A (en) 1979-08-01
JPS54104391A (en) 1979-08-16
DE2902400A1 (de) 1979-07-26
FR2415301B1 (fr) 1984-05-11
JPS6262289B2 (fr) 1987-12-25

Similar Documents

Publication Publication Date Title
FR2415301A1 (fr) Procede et composition pour determination par fixation specifique avec un recepteur double d'un ligand echantillon
JPS52117418A (en) Kit for quantitative analysis and method for using the same
EP0103558A3 (fr) Procédé pour l'exploitation quantitative d'une réaction d'affinité biospécifique
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
FR2458072A1 (fr) Procede, equipement et composition pour l'analyse qualitative et le dosage immuno-enzymatique de substances biologiques
GB8422452D0 (en) Assay
ES8306260A1 (es) "dispositivo para la determinacion de un analito biologico de interes utilizando agentes fluorescentes encapsulados".
EP0098590A3 (en) Immunoassay method
BE815426A (fr) Procede et appareil pour l'analyse quantitative utilisant un reactif en paricules
PT82296A (en) Process for the determination of glycatednglycosylated)hemoglobin in blood
DE3169833D1 (en) Process for performing analytical determinations by means of the chemiluminescent method, and application of this process to immuno assays
FR2395254A1 (fr) Procede de determination de la calcitonine serique par dosage radio-immunologique
BE747001A (fr) Dispositif de tube a echantillon, notamment pour l'analyse chimique ou biochimique
JPS574550A (en) Combination analysis reagent for measuring valproic acid
FR2396975A1 (fr) Procede de dosage d'hormones ou de produits pharmaceutiques non lies
BE859054A (fr) Procede de determination d'un reactif d'une reaction immunologique
GB9909661D0 (en) Assays for TSH receptor autoantibodies
MY103022A (en) Monoclonal antibodies recognizing l-thyroxine
FR2582103B1 (fr) Procede de determination d'une substance biologique dans un echantillon
JPS5714748A (en) Kit for quantitative determination of valproic acid and its method for quantitative determination
JPS5292773A (en) Automatic analyzer
FR2436185A1 (fr) Procede de determination de l'uree et composition utilisee dans ce procede
FR2376864A1 (fr) Reactif et procede de determination du cholecalciferol
JPS5436996A (en) Calcium analytical method
ES488774A1 (es) Procedimiento para la determinacion de la creatinquinasa mb

Legal Events

Date Code Title Description
CD Change of name or company name
TP Transmission of property